Dominic P. Behan

2014

In 2014, Dominic P. Behan earned a total compensation of $1.9M as Former Executive Vice President, Chief Scientific Officer and Director at Arena Pharmaceuticals, a 19% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$174,195
Option Awards$191,490
Salary$441,000
Stock Awards$1,059,600
Other$16,320
Total$1,882,605

Behan received $1.1M in stock awards, accounting for 56% of the total pay in 2014.

Behan also received $174.2K in non-equity incentive plan, $191.5K in option awards, $441K in salary and $16.3K in other compensation.

Rankings

In 2014, Dominic P. Behan's compensation ranked 4,765th out of 13,032 executives tracked by ExecPay. In other words, Behan earned more than 63.4% of executives.

ClassificationRankingPercentile
All
4,765
out of 13,032
63rd
Division
Manufacturing
1,706
out of 4,965
66th
Major group
Chemicals And Allied Products
560
out of 1,690
67th
Industry group
Drugs
428
out of 1,369
69th
Industry
Pharmaceutical Preparations
341
out of 1,042
67th
Source: SEC filing on April 28, 2017.

Behan's colleagues

We found six more compensation records of executives who worked with Dominic P. Behan at Arena Pharmaceuticals in 2014.

2014

Jack Lief

Arena Pharmaceuticals

Chief Executive Officer

2014

Steven Spector

Arena Pharmaceuticals

General Counsel

2014

William Shanahan

Arena Pharmaceuticals

Chief Medical Officer

2014

Robert Hoffman

Arena Pharmaceuticals

Chief Financial Officer

2014

Craig Audet

Arena Pharmaceuticals

Former Senior Vice President, Operations and Head of Global Regulatory Affairs

2014

Harry Hixson

Arena Pharmaceuticals

Chief Executive Officer

You may also like